4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001724521-24-000180
Chief Financial Officer gave up 10,099 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Goeltz II Robert C. Chief Financial Officer | 2024-12-15 | Shares withheld for taxes | −10,099 | $16.08 | $162,392 | 63,732 | D: show line 1 in the form |
Loading xslF345X05/wk-form4_1734485773.xml…